COVID-19相关性头痛与COVID-19疫苗相关性头痛的异同病例对照研究。

IF 0.8 4区 医学 Q4 CLINICAL NEUROLOGY Revista de neurologia Pub Date : 2023-11-16 DOI:10.33588/rn.7710.2023063
A González-Celestino, Y González-Osorio, C García-Iglesias, A Echavarría-Iñiguez, A Sierra-Mencía, A Recio-García, J Trigo-López, A Planchuelo-Gómez, M L Hurtado, L Sierra-Martínez, M Ruiz, M Rojas-Hernández, C Pérez-Almendro, M Paniagua, G Núñez, M Mora, C Montilla, C Martínez-Badillo, A G Lozano, A Gil, M Cubero, A Cornejo, I Calcerrada, M Blanco, A Alberdí-Iglesias, C Fernández-de-Las-Peñas, A L Guerrero-Peral, D García-Azorín
{"title":"COVID-19相关性头痛与COVID-19疫苗相关性头痛的异同病例对照研究。","authors":"A González-Celestino, Y González-Osorio, C García-Iglesias, A Echavarría-Iñiguez, A Sierra-Mencía, A Recio-García, J Trigo-López, A Planchuelo-Gómez, M L Hurtado, L Sierra-Martínez, M Ruiz, M Rojas-Hernández, C Pérez-Almendro, M Paniagua, G Núñez, M Mora, C Montilla, C Martínez-Badillo, A G Lozano, A Gil, M Cubero, A Cornejo, I Calcerrada, M Blanco, A Alberdí-Iglesias, C Fernández-de-Las-Peñas, A L Guerrero-Peral, D García-Azorín","doi":"10.33588/rn.7710.2023063","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction: </strong>Headache is a frequent symptom at the acute phase of coronavirus disease 2019 (COVID-19) and also one of the most frequent adverse effects following vaccination. In both cases, headache pathophysiology seems linked to the host immune response and could have similarities. We aimed to compare the clinical phenotype and the frequency and associated onset symptoms in patients with COVID-19 related-headache and COVID-19 vaccine related-headache.</p><p><strong>Subjects and methods: </strong>A case-control study was conducted. Patients with confirmed COVID-19 infection and COVID-19-vaccine recipients who experienced new-onset headache were included. A standardised questionnaire was administered, including demographic variables, prior history of headaches, associated symptoms and headache-related variables. Both groups were matched for age, sex, and prior history of headache. A multivariate regression analysis was performed.</p><p><strong>Results: </strong>A total of 238 patients fulfilled eligibility criteria (143 patients with COVID-19 related-headache and 95 subjects experiencing COVID-19 vaccine related-headache). Patients with COVID-19 related-headache exhibited a higher frequency of arthralgia, diarrhoea, dyspnoea, chest pain, expectoration, anosmia, myalgia, odynophagia, rhinorrhoea, cough, and dysgeusia. Further, patients with COVID-19 related-headache had a more prolonged daily duration of headache and described the headache as the worst headache ever experienced. Patients with COVID-19 vaccine-related headache, experienced more frequently pain in the parietal region, phonophobia, and worsening of the headache by head movements or eye movements.</p><p><strong>Conclusion: </strong>Headache caused by SARS-CoV-2 infection and COVID-19 vaccination related-headache have more similarities than differences, supporting a shared pathophysiology, and the activation of the innate immune response. The main differences were related to associated symptoms.</p>","PeriodicalId":21281,"journal":{"name":"Revista de neurologia","volume":"77 10","pages":"229-239"},"PeriodicalIF":0.8000,"publicationDate":"2023-11-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831767/pdf/","citationCount":"0","resultStr":"{\"title\":\"Differences and similarities between COVID-19 related-headache and COVID-19 vaccine related-headache. A case-control study.\",\"authors\":\"A González-Celestino, Y González-Osorio, C García-Iglesias, A Echavarría-Iñiguez, A Sierra-Mencía, A Recio-García, J Trigo-López, A Planchuelo-Gómez, M L Hurtado, L Sierra-Martínez, M Ruiz, M Rojas-Hernández, C Pérez-Almendro, M Paniagua, G Núñez, M Mora, C Montilla, C Martínez-Badillo, A G Lozano, A Gil, M Cubero, A Cornejo, I Calcerrada, M Blanco, A Alberdí-Iglesias, C Fernández-de-Las-Peñas, A L Guerrero-Peral, D García-Azorín\",\"doi\":\"10.33588/rn.7710.2023063\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction: </strong>Headache is a frequent symptom at the acute phase of coronavirus disease 2019 (COVID-19) and also one of the most frequent adverse effects following vaccination. In both cases, headache pathophysiology seems linked to the host immune response and could have similarities. We aimed to compare the clinical phenotype and the frequency and associated onset symptoms in patients with COVID-19 related-headache and COVID-19 vaccine related-headache.</p><p><strong>Subjects and methods: </strong>A case-control study was conducted. Patients with confirmed COVID-19 infection and COVID-19-vaccine recipients who experienced new-onset headache were included. A standardised questionnaire was administered, including demographic variables, prior history of headaches, associated symptoms and headache-related variables. Both groups were matched for age, sex, and prior history of headache. A multivariate regression analysis was performed.</p><p><strong>Results: </strong>A total of 238 patients fulfilled eligibility criteria (143 patients with COVID-19 related-headache and 95 subjects experiencing COVID-19 vaccine related-headache). Patients with COVID-19 related-headache exhibited a higher frequency of arthralgia, diarrhoea, dyspnoea, chest pain, expectoration, anosmia, myalgia, odynophagia, rhinorrhoea, cough, and dysgeusia. Further, patients with COVID-19 related-headache had a more prolonged daily duration of headache and described the headache as the worst headache ever experienced. Patients with COVID-19 vaccine-related headache, experienced more frequently pain in the parietal region, phonophobia, and worsening of the headache by head movements or eye movements.</p><p><strong>Conclusion: </strong>Headache caused by SARS-CoV-2 infection and COVID-19 vaccination related-headache have more similarities than differences, supporting a shared pathophysiology, and the activation of the innate immune response. The main differences were related to associated symptoms.</p>\",\"PeriodicalId\":21281,\"journal\":{\"name\":\"Revista de neurologia\",\"volume\":\"77 10\",\"pages\":\"229-239\"},\"PeriodicalIF\":0.8000,\"publicationDate\":\"2023-11-16\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10831767/pdf/\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Revista de neurologia\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.33588/rn.7710.2023063\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q4\",\"JCRName\":\"CLINICAL NEUROLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Revista de neurologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.33588/rn.7710.2023063","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"CLINICAL NEUROLOGY","Score":null,"Total":0}
引用次数: 0

摘要

简介:头痛是2019冠状病毒病(COVID-19)急性期的常见症状,也是接种疫苗后最常见的不良反应之一。在这两种情况下,头痛的病理生理似乎与宿主免疫反应有关,并且可能有相似之处。我们的目的是比较COVID-19相关性头痛和COVID-19疫苗相关性头痛患者的临床表型、频率和相关发病症状。对象和方法:采用病例对照研究。纳入确诊的COVID-19感染患者和新发头痛的COVID-19疫苗接种者。进行标准化问卷调查,包括人口统计变量、头痛病史、相关症状和头痛相关变量。两组的年龄、性别和头痛病史都是匹配的。进行多元回归分析。结果:238例患者符合入选标准,其中143例为新冠肺炎相关头痛,95例为新冠肺炎疫苗相关头痛。与COVID-19相关的头痛患者出现关节痛、腹泻、呼吸困难、胸痛、咳痰、嗅觉减退、肌痛、咽痛、鼻漏、咳嗽和嗅觉障碍的频率更高。此外,患有COVID-19相关头痛的患者每天的头痛持续时间更长,并将头痛描述为有史以来最严重的头痛。患有COVID-19疫苗相关头痛的患者更频繁地出现顶叶区域疼痛、声音恐惧症以及头部运动或眼球运动导致头痛恶化。结论:SARS-CoV-2感染引起的头痛与COVID-19疫苗接种相关的头痛相似多于差异,支持共同的病理生理和先天免疫反应的激活。主要差异与相关症状有关。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Differences and similarities between COVID-19 related-headache and COVID-19 vaccine related-headache. A case-control study.

Introduction: Headache is a frequent symptom at the acute phase of coronavirus disease 2019 (COVID-19) and also one of the most frequent adverse effects following vaccination. In both cases, headache pathophysiology seems linked to the host immune response and could have similarities. We aimed to compare the clinical phenotype and the frequency and associated onset symptoms in patients with COVID-19 related-headache and COVID-19 vaccine related-headache.

Subjects and methods: A case-control study was conducted. Patients with confirmed COVID-19 infection and COVID-19-vaccine recipients who experienced new-onset headache were included. A standardised questionnaire was administered, including demographic variables, prior history of headaches, associated symptoms and headache-related variables. Both groups were matched for age, sex, and prior history of headache. A multivariate regression analysis was performed.

Results: A total of 238 patients fulfilled eligibility criteria (143 patients with COVID-19 related-headache and 95 subjects experiencing COVID-19 vaccine related-headache). Patients with COVID-19 related-headache exhibited a higher frequency of arthralgia, diarrhoea, dyspnoea, chest pain, expectoration, anosmia, myalgia, odynophagia, rhinorrhoea, cough, and dysgeusia. Further, patients with COVID-19 related-headache had a more prolonged daily duration of headache and described the headache as the worst headache ever experienced. Patients with COVID-19 vaccine-related headache, experienced more frequently pain in the parietal region, phonophobia, and worsening of the headache by head movements or eye movements.

Conclusion: Headache caused by SARS-CoV-2 infection and COVID-19 vaccination related-headache have more similarities than differences, supporting a shared pathophysiology, and the activation of the innate immune response. The main differences were related to associated symptoms.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Revista de neurologia
Revista de neurologia 医学-临床神经学
CiteScore
2.50
自引率
8.30%
发文量
117
审稿时长
3-8 weeks
期刊介绍: Revista de Neurología fomenta y difunde el conocimiento generado en lengua española sobre neurociencia, tanto clínica como experimental.
期刊最新文献
The Efficacy of Boxing Training on Patients with Parkinson's Disease: Systematic Review and Meta-Analysis. [Referral Profile of Adult Patients Attended in the Neuropsychology Consultation at Hospital Universitario La Paz in Madrid from 2018 to 2023]. [Characteristics of patients with drug-resistant epilepsy in a tertiary hospital]. [Glioblastoma and its interaction with neurogenesis]. [The p-value of a test is not the probability that the null hypothesis is true or false].
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1